Keywords
Last Name
Institution

Funding Agency: Pfizer
Title: A Phase II Study of Sunitinib in Recurrent, Refractory or Progressive High Grade Glioma and Ependymoma Tumors in Pediatric and Young Adult Patients
Start Date: 2013-01-01


Collapse Overview 
Collapse researcher role of